STERIS Past Earnings Performance
Past criteria checks 0/6
STERIS's earnings have been declining at an average annual rate of -0.4%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 13% per year.
Key information
-0.4%
Earnings growth rate
-2.3%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 13.0% |
| Return on equity | -0.2% |
| Net Margin | -0.2% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How STERIS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 4,777 | -8 | 1,361 | 101 |
| 30 Jun 22 | 4,773 | 377 | 1,369 | 95 |
| 31 Mar 22 | 4,585 | 244 | 1,297 | 88 |
| 31 Dec 21 | 4,248 | 279 | 1,081 | 79 |
| 30 Sep 21 | 3,848 | 250 | 950 | 71 |
| 30 Jun 21 | 3,407 | 286 | 793 | 68 |
| 31 Mar 21 | 3,108 | 397 | 696 | 66 |
| 31 Dec 20 | 3,057 | 433 | 683 | 66 |
| 30 Sep 20 | 3,022 | 424 | 679 | 66 |
| 30 Jun 20 | 3,003 | 413 | 685 | 66 |
| 31 Mar 20 | 3,031 | 408 | 709 | 66 |
| 31 Dec 19 | 2,976 | 393 | 676 | 64 |
| 30 Sep 19 | 2,898 | 336 | 683 | 63 |
| 30 Jun 19 | 2,840 | 319 | 665 | 62 |
| 31 Mar 19 | 2,782 | 304 | 645 | 63 |
| 31 Dec 18 | 2,730 | 269 | 637 | 65 |
| 30 Sep 18 | 2,696 | 316 | 622 | 65 |
| 30 Jun 18 | 2,651 | 303 | 618 | 63 |
| 31 Mar 18 | 2,620 | 291 | 616 | 61 |
| 31 Dec 17 | 2,585 | 243 | 650 | 59 |
| 30 Sep 17 | 2,570 | 144 | 630 | 58 |
| 30 Jun 17 | 2,582 | 120 | 640 | 59 |
| 31 Mar 17 | 2,613 | 110 | 652 | 59 |
| 31 Dec 16 | 2,616 | 142 | 523 | 58 |
| 30 Sep 16 | 2,588 | 167 | 560 | 58 |
| 30 Jun 16 | 2,431 | 135 | 569 | 57 |
| 31 Mar 16 | 2,233 | 111 | 544 | 57 |
Quality Earnings: 2TG is currently unprofitable.
Growing Profit Margin: 2TG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2TG is unprofitable, and losses have increased over the past 5 years at a rate of 0.4% per year.
Accelerating Growth: Unable to compare 2TG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2TG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: 2TG has a negative Return on Equity (-0.16%), as it is currently unprofitable.